相关实验视频

Updated: Feb 28, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

固体瘤免疫疗法的NKG2DCAR-T细胞:进展,挑战和未来的方向

Chen Liu¹, Zhiqiang Wang², Wentao Zhang³

¹Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.

Frontiers in immunology

|February 27, 2026

概括

NKG2D CAR-T细胞疗法通过向应激配体和克服免疫抑制瘤微环境 (TME) 来治疗固体瘤具有前景. 在CAR设计和组合策略的进步旨在提高有效性和耐用性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

化学抗原受体 (CAR) T细胞疗法在血液癌症中有效,但由于免疫抑制性瘤微环境 (TME),在固体瘤中受到限制.
NKG2D CAR-T细胞在瘤细胞上准NKG2D配体 (NKG2DLs),提供了克服TME媒介抑制的潜力.

研究的目的:

审查NKG2DCAR-T细胞对固体瘤的策略的最新进展.
讨论CAR架构,信号,组合免疫疗法和装甲CAR结构的创新.
探索固体瘤CAR-T细胞治疗的治疗潜力,挑战和未来方向.

主要方法:

关于NKG2D CAR-T细胞治疗固体瘤的最新科学文献的综述.
分析CAR设计的创新,包括信号通道和装甲结构.
讨论组合免疫疗法方法.

主要成果:

NKG2D CAR-T细胞显示出在固体TME中克服免疫抑制障碍的潜力.
在CAR架构,信号和装甲结构中的创新正在增强治疗策略.
组合免疫疗法显示出改善结果的希望.

结论:

NKG2D CAR-T细胞疗法是固体瘤的一个有希望的方法,解决了TME的局限性.
对CAR设计和组合策略的持续研究对于开发有效疗法至关重要.
未来的方向侧重于增强CAR-T细胞的持久性和功能,以获得持久的反应.

关键词:

在 NKG2D CAR-T 细胞中.在TME中,它是最重要的.组合疗法治疗组合治疗.工程设计工程设计工程设计固体瘤是一种固体瘤.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

A Spheroid Killing Assay by CAR T Cells

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...